在摩洛哥检测到的德尔塔变种（B.1.617.2）和卡帕变种（B.1.617.1）的基因组序列
Genome Sequences of the Delta Variant (B.1.617.2) and the Kappa Variant (B.1.617.1) Detected in Morocco.
作者信息
Melloul Marouane, Chouati Taha, Hemlali Mouhssine, Alaoui Amine Sanaa, Touil Nadia, Elannaz Hicham, Ennibi Khalid, Youbi Mohammed, Merabet Mouad, Bellefquih Abdelkrim Meziane, Nourlil Jalal, Maaroufi Abderrahmane, El Fahime Elmostafa
机构信息
Molecular Biology and Functional Genomics Platform, National Center for Scientific and Technical Research (CNRST), Rabat, Morocco.
Genomic Center for Human Pathologies (GENOPATH), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
出版信息
Microbiol Resour Announc. 2021 Sep 30;10(39):e0072721. doi: 10.1128/MRA.00727-21.
Abstract
Here, we report the identification and coding-complete genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains obtained from patients with COVID-19. The strains identified belong to variant of concern B.1.617.2 and variant of interest B.1.617.1.
摘要
在此，我们报告了从新冠肺炎患者中获得的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）毒株的鉴定结果和编码完整的基因组序列。鉴定出的毒株属于值得关注的变异株B.1.617.2和值得关注的变异株B.1.617.1。
相似文献
1
Genome Sequences of the Delta Variant (B.1.617.2) and the Kappa Variant (B.1.617.1) Detected in Morocco.
Microbiol Resour Announc. 2021 Sep 30;10(39):e0072721. doi: 10.1128/MRA.00727-21.
2
Coding-Complete Genome Sequences of a Delta Subvariant (AY.33) of SARS-CoV-2 Obtained from Moroccan COVID-19 Patients.
Microbiol Resour Announc. 2022 Feb 17;11(2):e0109921. doi: 10.1128/mra.01099-21. Epub 2022 Feb 3.
3
Phylogeography and genomic analysis of SARS-CoV-2 delta variant in Morocco.
J Infect Dev Ctries. 2022 Aug 30;16(8):1258-1268. doi: 10.3855/jidc.16513.
4
Genome Sequencing Reveals a Mixed Picture of SARS-CoV-2 Variant of Concern Circulation in Eastern Uttar Pradesh, India.
Front Med (Lausanne). 2022 Jan 7;8:781287. doi: 10.3389/fmed.2021.781287. eCollection 2021.
5
Coding-Complete Genome Sequences of Alpha and Delta SARS-CoV-2 Variants from Kamphaeng Phet Province, Thailand, from May to July 2021.
Microbiol Resour Announc. 2021 Dec 2;10(48):e0087721. doi: 10.1128/MRA.00877-21.
6
A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
J Infect Public Health. 2022 Aug;15(8):878-891. doi: 10.1016/j.jiph.2022.07.002. Epub 2022 Jul 8.
7
SARS-CoV-2 Delta Variant among Asiatic Lions, India.
Emerg Infect Dis. 2021 Oct;27(10):2723-2725. doi: 10.3201/eid2710.211500.
8
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant.
Pathology. 2022 Apr;54(3):351-356. doi: 10.1016/j.pathol.2022.01.001. Epub 2022 Jan 31.
9
Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients.
Infect Genet Evol. 2022 Jun;100:105278. doi: 10.1016/j.meegid.2022.105278. Epub 2022 Mar 31.
10
Coding-Complete Sequence of a SARS-CoV-2 Strain from an Omicron (B.1.1.529+BA.1) Variant Detected in Morocco.
Microbiol Resour Announc. 2022 May 19;11(5):e0006322. doi: 10.1128/mra.00063-22. Epub 2022 Apr 14.
引用本文的文献
1
SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.
Front Public Health. 2023 Oct 10;11:1044788. doi: 10.3389/fpubh.2023.1044788. eCollection 2023.
2
The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic.
Polym Bull (Berl). 2022 Nov 21:1-27. doi: 10.1007/s00289-022-04579-3.
3
Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants.
Biomolecules. 2022 Nov 11;12(11):1673. doi: 10.3390/biom12111673.
4
SARS-CoV-2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice.
Small. 2022 Jun;18(25):e2200836. doi: 10.1002/smll.202200836. Epub 2022 May 23.
5
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies.
Nanoscale. 2022 Jan 27;14(4):1054-1074. doi: 10.1039/d1nr03831a.
本文引用的文献
1
Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method.
China CDC Wkly. 2020 Jun 19;2(25):447-452. doi: 10.46234/ccdcw2020.088.
2
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
Nature. 2021 Mar;591(7849):293-299. doi: 10.1038/s41586-021-03237-4. Epub 2021 Jan 25.
3
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.
Cell. 2020 Sep 3;182(5):1284-1294.e9. doi: 10.1016/j.cell.2020.07.012. Epub 2020 Jul 17.
4
Mutations Strengthened SARS-CoV-2 Infectivity.
J Mol Biol. 2020 Sep 4;432(19):5212-5226. doi: 10.1016/j.jmb.2020.07.009. Epub 2020 Jul 23.
5
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
Nat Microbiol. 2020 Nov;5(11):1403-1407. doi: 10.1038/s41564-020-0770-5. Epub 2020 Jul 15.
6
A new coronavirus associated with human respiratory disease in China.
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
7
Unipro UGENE: a unified bioinformatics toolkit.
Bioinformatics. 2012 Apr 15;28(8):1166-7. doi: 10.1093/bioinformatics/bts091. Epub 2012 Feb 24.
Zotero 插件